Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Adial Pharmaceuticals, Inc. Transaction History

Empirical Financial Services, LLC D.B.A. Empirical Wealth Management

  • $3.37 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022
SELL
$28.0 - $53.25 $280,000 - $532,500
-10,000 Reduced 28.57%
25,000 $34,000
Q1 2022

May 13, 2022
BUY
$45.0 - $69.0 $1.58 Million - $2.42 Million
35,000 New
35,000 $70,000

Others Institutions Holding ADIL

# of Institutions
1
Shares Held
5.5K
Call Options Held
0
Put Options Held
0
View Full List

About ADIAL PHARMACEUTICALS, INC.

ADIL Quotes by TradingView
  • Ticker ADIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,854,000
  • Market Cap $26M
  • Description
  • Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...
More about ADIL
Track This Portfolio

Track Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Portfolio

Follow Empirical Financial Services, LLC D.B.A. Empirical Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Financial Services, LLC D.B.A. Empirical Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email